echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Eur Radiol: How to accurately measure the volume of necrotic tissue after radiofrequency ablation of benign thyroid nodules

    Eur Radiol: How to accurately measure the volume of necrotic tissue after radiofrequency ablation of benign thyroid nodules

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the guidelines, radiofrequency ablation (RFA) is a safe and effective method for the treatment of benign thyroid nodules.


    According to the guidelines, radiofrequency ablation (RFA) is a safe and effective method for the treatment of benign thyroid nodules.


    Evaluation indicators after ablation include volume reduction rate (VRR), treatment success rate, etc.


    Contrast-enhanced ultrasound (CEUS) is a harmonic contrast imaging technique, contrast agents by using a second generation evaluation micro vessels for the detection and characterization of focal lesions.


    Recently, a study published in the journal European Radiology explored the observers of gray-scale and Doppler ultrasound (US) and contrast-enhanced ultrasound (CEUS) measuring the ablation volume (Va) of benign thyroid nodules after radiofrequency ablation (RFA) Reliability and consistency within and between observers.


    A total of 190 benign thyroid nodules in 173 patients were included in this study, and each patient received radiofrequency ablation.


    A total of 190 benign thyroid nodules in 173 patients were included in this study, and each patient received radiofrequency ablation.


    The average follow-up time was 23.


    Table Bland-Altman analysis of the consistency between conventional US and CEUS

    Table Bland-Altman analysis of the consistency between conventional US and CEUS

    The Bland-Altman chart of the consistency of the measurement results of the two treatment methods during the follow-up.


    The Bland-Altman chart of the consistency of the measurement results of the two treatment methods during the follow-up.


        The internal and inter-observer reliability and consistency of the US and CEUS in measuring Va are not satisfactory.


    Original source: Original source:

    Lin Yan,Yukun Luo,Jing Xiao,et al.


    Lin Yan,Yukun Luo,Jing Xiao,et al.
    Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
    DOI: org/10.
    1007/s00330-020-07398-0">10.
    1007/s00330-020- 07398-0 Lin Yan,Yukun Luo,Jing Xiao,et al.
    Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
    DOI: org/10.
    1007/s00330-020-07398-0">10.
    1007/s00330 -020-07398-0org/10.
    1007/s00330-020-07398-0"> 10.
    1007/s00330-020-07398-0 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.